Literature DB >> 8598096

Detection of prostate-specific antigen mRNA and protein in breast tumors.

N Zarghami1, E P Diamandis.   

Abstract

We have developed reverse transcription-polymerase chain reaction (RT- PCR) methods for detecting prostate-specific antigen (PSA) mRNA. Using these methods, and a highly sensitive immunofluorometric assay for measuring PSA protein, we have assessed the concentrations of PSA mRNA and PSA protein in 30 primary breast tumors and a few other control tissues. We found good agreement between presence of PSA protein and PSA mRNA in breast tumors. We thus propose that, in women, detection of PSA protein or PSA mRNA in tissues and tumors offers equivalent information. Because PSA protein is present in male blood and thus could contaminate extracts from tumors and tissues from men, we propose that the RT-PCR methods we describe be used to assess nonprostatic expression of the PSA gene in men.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8598096

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.

Authors:  A Ylikoski; M Karp; K Pettersson; H Lilja; T Lövgren
Journal:  J Mol Diagn       Date:  2001-08       Impact factor: 5.568

2.  Amplification of human genomic DNA sequences with polymerase chain reaction using a single oligonucleotide primer.

Authors:  L Luo; E P Diamandis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 3.  Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?

Authors:  F Mannello; G Gazzanelli
Journal:  Breast Cancer Res       Date:  2001-05-10       Impact factor: 6.466

4.  Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.

Authors:  Shuko Saku; Uhi Toh; Yuko Takao; Sayaka Sakurai; Akira Yamada; Shigeki Shichijo; Kyogo Itoh; Yoshito Akagi
Journal:  Exp Ther Med       Date:  2021-06-25       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.